ADVANCE EXTENSION - A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects with PAH via an Open-Label Extension
-
Enrollment
This study is not currently enrolling. -
Research Area
Heart, Lung and Vascular Research -
Principal Investigator
-
Sponsor
United Therapeutics
If you have taken part in a research study with ralinepag, the investigational study drug, you may be able to take part in this extension study. This means that all participants will receive the investigational study drug to look at its safety and effects when used with your current oral PAH treatments over a longer period.